课题基金 / 基金详情

ROSIGLITAZONE THRPY FOR PREV OF COR ARTERY DISEASE IN PTS W/IMPAIRD GLUCOSE TOL

ROSIGLITAZONE THRPY FOR PREV OF COR ARTERY DISEASE IN PTS W/IMPAIRD GLUCOSE TOL
罗格列酮苏吡酮用于预防葡萄糖耐受不良患者的冠状动脉疾病
批准号:
7604394
负责人:
JANE E REUSCH
金额:
$0.84万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2008-03-31

项目摘要

项目成果

JANE E REUSCH的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an 18-month study looking at prevention of coronary artery disease progression in people with impaired glucose tolerance on rosiglitazone vs. placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injury
  • 批准号:
    10319430
  • 项目类别:
  • 资助金额:
    $39.86万
  • 财政年份:
    2021
  • 负责人:
    JANE E REUSCH
  • 依托单位:
Incidence and severity of new onset diabetes associated with SARS-CoV-2 infection
  • 批准号:
    10632720
  • 项目类别:
  • 资助金额:
    $40.6万
  • 财政年份:
    2021
  • 负责人:
    JANE E REUSCH
  • 依托单位:
P and F Program
  • 批准号:
    10392982
  • 项目类别:
  • 资助金额:
    $34.4万
  • 财政年份:
    2020
  • 负责人:
    JANE E REUSCH
  • 依托单位:
P and F Program
  • 批准号:
    10646163
  • 项目类别:
  • 资助金额:
    $34.4万
  • 财政年份:
    2020
  • 负责人:
    JANE E REUSCH
  • 依托单位: